Skip to content
Peptigraph home

AOD-9604 reconstitution calculator

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Educational use only
1Vial size
2Bacteriostatic water added
3Dose per injection
4Syringe (U-100)
Draw to
12units
= 0.12 mL on a 1 mL U-100 insulin syringe
5 mg vial2 mL water300 mcg dose
Concentration
2.5 mg/mL
Doses per vial
16
Weeks (1 dose/wk)
16
Math only. It does not recommend a dose. AOD-9604: Not FDA approved · research chemical.

12 units (0.12 mL) on a 1 mL U-100 syringe: 300 mcg from a 5 mg vial + 2 mL water (AOD-9604).

Dosing table for a 5 mg vial

Syringe units (U-100) for each dose, by how much bacteriostatic water you add.

AOD-9604: U-100 syringe units per dose for a 5 mg vial
Dose1 mL water2 mL water2.5 mL water3 mL water
100 mcg2456
250 mcg51012.515
300 mcg6121518
500 mcg10202530
750 mcg153037.545
1000 mcg20405060

How the math works

Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.

5 mg ÷ 2 mL = 2.5 mg/mL
300 mcg = 0.3 mg; 0.3 mg ÷ 2.5 mg/mL = 0.12 mL
0.12 mL × 100 = 12 units

How many units is 300 mcg of AOD-9604?

With a 5 mg vial and 2 mL of bacteriostatic water, 300 mcg is 12 units (0.12 mL) on a U-100 syringe. With 1 mL of water it is 6 units. The answer always depends on how much water was added.

How much bacteriostatic water for a 5 mg AOD-9604 vial?

The water only sets the concentration; the amount of AOD-9604 in the vial stays the same. 2 mL makes 2.5 mg/mL, so 300 mcg is 12 units. 2.5 mL makes 2 mg/mL, so the same 300 mcg is 15 units. More water makes small doses easier to measure but needs more volume per injection.

How many 300 mcg doses are in a 5 mg vial?

5 mg is 5,000 mcg; 5,000 ÷ 300 = 16.67, so 16 full doses of 300 mcg. Any liquid lost in the needle and vial is not counted.

What does an AOD-9604 5mg vial give per unit?

Mixed with 2 mL, a 5 mg vial is 2.5 mg/mL and each unit is 0.025 mg, or 25 mcg; mixed with 1 mL each unit is 50 mcg.

Calculated from vial mg 5; water m L 1, 2. Formula: 5/2 = 2.5 mg/mL x 0.01 = 0.025 mg; 5/1 = 5 mg/mL x 0.01 = 0.05 mg

How to reconstitute AOD-9604?

There is no label for it. The tool follows the generic rule that strength is vial mg divided by water mL, so a 10 mg vial in 2 mL is 5 mg/mL.

Calculated from vial mg 10; water m L 2. Formula: 10/2 = 5 mg/mL

Is there a human AOD-9604 dose in the studies?

Not in the evidence file: the dose-bearing studies are in rats, mice and rabbits, and the oral rat dose was weight-based.[3]

Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for AOD-9604 in community discussions.

12 units · 0.12 mL · 300 mcg from 5 mg + 2 mL

Every AOD-9604 dose on record is an animal dose, and none is a syringe dose

The rat study that gave a dose per kilogram used the oral route: 500 microg/kg by mouth daily for 19 days in obese Zucker rats.[3]

The mouse experiments delivered the peptide by mini-osmotic pump for 14 days, so no per-injection amount exists to convert.[4]

A separate mouse study gave AOD9604 by intraperitoneal injection for 14 days, again without a stated mass in the abstract.[5]

The rabbit osteoarthritis study is the closest to a measurable injection: 0.25 mg of AOD9604 injected into the knee joint weekly, with or without 6 mg of hyaluronic acid.[6]

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.Hormone research · 2000PMID 11146367Accessed 2 Oct 2026
  4. 4Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001PMID 11673763Accessed 2 Oct 2026
  5. 5The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.Endocrinology · 2001PMID 11713213Accessed 2 Oct 2026
  6. 6Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.Annals of clinical and laboratory science · 2015PMID 26275694Accessed 2 Oct 2026

Found an error? Report a correction.